SEC Form 4 · accession 0001209191-18-041678
Orthofix Medical Inc. · OFIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley V. Niemann
Officer — President of Global Spine
Period of report
Jul 2, 2018
Accepted (ET)
Jul 5, 2018 · 4:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 2, 2018 | A | 2,989 | $0.00 | A | 26,992 | D | |
| Common Stock | Jul 3, 2018 | M | 5,000 | $27.37 | A | 31,992 | D | |
| Common Stock | Jul 3, 2018 | M | 6,250 | $21.78 | A | 38,242 | D | |
| Common StockF3 | Jul 3, 2018 | S | 9,100 | $56.9369 | D | 29,142 | D | |
| Common StockF4 | Jul 3, 2018 | S | 2,150 | $57.3532 | D | 26,992 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $27.37 | Jul 3, 2018 | M | 5,000 | D | Jul 1, 2017 | Jul 1, 2023 | Common Stock | 5,000 | 0 | D |
| Stock Option (right to buy) | $21.78 | Jul 3, 2018 | M | 6,250 | D | Sep 26, 2017 | Sep 26, 2023 | Common Stock | 6,250 | 0 | D |
Explanation of responses
- F1Represents time-based vesting restricted stock that vests in 25% increments on the first, second, third and fourth anniversaries of the grant date, July 2, 2018.
- F2The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b-5-1 trading plan adopted by the reporting person on November 9,2017.
- F3The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.27 to $57.25, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- F4The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.27 to $57.45, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4) to this Form 4.